Arcadia Biosciences, Inc. (RKDA)

Market Cap	6.14M
Revenue (ttm)	5.26M
Net Income (ttm)	-2.02M
Shares Out	1.37M
EPS (ttm)	-1.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,141
Open	4.670
Previous Close	4.750
Day's Range	4.120 - 4.790
52-Week Range	2.400 - 10.310
Beta	0.50
Analysts	Strong Buy
Price Target	6.00 (+33.63%)
Earnings Date	Aug 12, 2025

About RKDA

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

• Industry: Packaged Foods
• Sector: Consumer Staples
• IPO Date: May 15, 2015
• Employees: 9
• Stock Exchange: NASDAQ
• Ticker Symbol: RKDA
• Website: https://www.arcadiabio.com

Financial Performance

In 2024, Arcadia Biosciences's revenue was $5.05 million, an increase of 13.27% compared to the previous year's $4.45 million. Losses were -$7.04 million, -49.66% less than in 2023.

Analyst Summary

According to one analyst, the rating for RKDA stock is "Strong Buy" and the 12-month stock price target is $6.0.

Price Target

$6.0

(33.63% upside)

Analyst Consensus: Strong Buy